Pump failure death and sudden cardiac death in patients with cardiac dysfunction: a search for prognostic predictive

Hiroki Usuku1, Masafumi Nakayama, Hitoshi Sumida

  • 1Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto City 860-8556, Japan. uhuhuhuh@kumamoto-u.ac.jp

Journal of Cardiology
|February 4, 2010
PubMed

Insights

Predicting long-term heart failure death is crucial. B-type natriuretic peptide (BNP) predicts pump failure death, while estimated glomerular filtration rate (eGFR) predicts sudden cardiac death in myocardial infarction patients.

Area of Science:

  • Cardiology
  • Biomarkers
  • Renal Function

Background:

  • Long-term prediction of heart failure mortality remains challenging.
  • Heart failure deaths are categorized into pump failure and sudden cardiac death.
  • Few studies have comprehensively analyzed predictive factors for these distinct mortality types.

Purpose of the Study:

  • To identify independent predictors for pump failure death and sudden cardiac death in patients with myocardial infarction (MI) and non-ischemic heart failure (NIHF).
  • To elucidate the long-term prognostic value of B-type natriuretic peptide (BNP) and estimated glomerular filtration rate (eGFR) in heart failure mortality.

Main Methods:

  • Prospective follow-up of 186 MI patients and 115 NIHF patients for approximately 73 months.
  • Multivariate analysis to determine independent predictors of mortality.
  • Kaplan-Meier analysis to assess survival rates based on biomarker levels.

Main Results:

  • Log B-type natriuretic peptide (BNP) levels independently predicted pump failure death in both MI and NIHF groups.
  • Estimated glomerular filtration rate (eGFR) independently predicted sudden cardiac death specifically in MI patients.
  • High BNP levels were associated with increased pump failure death risk; low eGFR was linked to higher sudden cardiac death rates in MI patients.

Conclusions:

  • Plasma BNP levels serve as a robust independent predictor for pump failure death across both ischemic and non-ischemic heart failure etiologies.
  • Estimated glomerular filtration rate (eGFR) is a significant independent predictor for sudden cardiac death in patients with myocardial infarction.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...